- Home
- Applications
- usa massachusetts
- administration of drug
Show results for
Refine by
Administration Of Drug Product Applications In Usa Massachusetts
3 applications found
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
GI Dynamics has taken all necessary COVID-19 precautions to ensure patient safety, which remains top priority. Patient screening for the STEP-1 pivotal trial of EndoBarrier has reopened at select sites and enrollment will be conducted according to site requirements and CDC/FDA ...
ByGI Dynamics, Inc. based in Boston, MASSACHUSETTS (USA)
From reusable and implantable medical devices to medical tubing, textiles and beyond, Sciessent’s antimicrobial technology can help protect against bacteria growth. ...
BySciessent LLC based in Beverly, MASSACHUSETTS (USA)